2
Clinical Trials associated with Zhilong Huayu Capsule蛭丹化瘀胶囊治疗子宫内膜异位症所致继发性痛经(气滞血瘀证)评价其有效性和安全性的临床试验
[Translation] Clinical trial to evaluate the efficacy and safety of Zhidan Huayu Capsule in the treatment of secondary dysmenorrhea (Qi stagnation and blood stasis syndrome) caused by endometriosis
1.探索评价蛭丹化瘀胶囊对子宫内膜异位症所致继发性痛经的治疗作用,以及对子宫内膜异位症气滞血瘀证的证候改善作用。 2.观察蛭丹化瘀胶囊的临床应用的安全性。
[Translation] 1. To explore and evaluate the therapeutic effect of Zhidan Huayu Capsule on secondary dysmenorrhea caused by endometriosis, and its effect on improving the symptoms of qi stagnation and blood stasis in endometriosis. 2. To observe the safety of Zhidan Huayu Capsule in clinical application.
/ SuspendedEarly Phase 1IIT Study on Key Technology of Zhilong Huoxue Tongyu Capsule in Prevention and Treatment of Hypertensive Myocardial Fibrosis
Start Date10 Apr 2023 |
Sponsor / Collaborator- |
100 Clinical Results associated with Zhilong Huayu Capsule
100 Translational Medicine associated with Zhilong Huayu Capsule
100 Patents (Medical) associated with Zhilong Huayu Capsule
100 Deals associated with Zhilong Huayu Capsule